Circulation, Vol 73, 1065-1076, Copyright © 1986 by American Heart Association
KP Gallagher, AJ Buda, D Pace, RA Gerren and M Shlafer
Superoxide dismutase (SOD) and catalase (CAT), enzymes that degrade
superoxide anion and hydrogen peroxide, respectively, reduce size of
infarction in anesthetized, open-chest dogs subjected to coronary occlusion
followed by reperfusion. To evaluate potential protective effects of these
enzymes in conscious animals, three groups of dogs were instrumented at
sterile surgery with a hydraulic occluder on the left circumflex (LCX)
coronary artery, sonomicrometers to measure regional wall thickness, and
catheters to monitor arterial and left ventricular pressures. Ten to 14
days after surgery, the animals were sedated with morphine sulfate (0.5
mg/kg). The LCX artery was occluded for 3 hr by inflation of the hydraulic
cuff. Infusions of SOD (n = 7), CAT (n = 6), or saline (control group, n =
7) were begun 15 min before reperfusion and lasted for 45 min of
reperfusion. The doses of SOD and CAT were 5 mg/kg, dissolved in 60 ml of
saline, and infused at a rate of 1 ml/min. Myocardial blood flow was
measured with tracer-labeled microspheres (15 micron diameter) before
occlusion, after 5 to 10 min of occlusion, after 150 min of occlusion, and
5 to 10 min after reperfusion. Size of infarction was measured 24 hr later
by dual- perfusion staining with Evans blue and triphenyl tetrazolium. Size
of infarction (expressed as a percentage of area at risk) did not differ
significantly among the three groups: control, 32 +/- 17% (mean +/- SD);
SOD, 38 +/- 17%; CAT, 27 +/- 17%. Hemodynamic parameters and myocardial
blood flows (measured before infusion of any agents) were not significantly
different among the three groups. Serum SOD levels in SOD-treated dogs were
19 +/- 2 micrograms/ml at the onset of reperfusion and 29 +/- 3
micrograms/ml at the end of the infusion. Blood assays collected after
infusion showed a monoexponential decay of SOD levels with a half-life of
22 +/- 6 min. We conclude that myocardial protection by SOD or CAT is model
dependent. In conscious dogs subjected to 3 hr of coronary occlusion
followed by reperfusion, SOD and CAT failed to alter size of infarction.
ARTICLES
Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion
This article has been cited by other articles:
![]() |
E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fukushima, S. R. Coppen, A. Varela-Carver, G. Brindley, K. Yamahara, P. Sarathchandra, M. H. Yacoub, and K. Suzuki Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration Cardiovasc Res, February 1, 2006; 69(2): 459 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Jones, M. R. Hoffmeyer, B. R. Sharp, Y.-S. Ho, and D. J. Lefer Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H277 - H282. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Jones, S. D. Trocha, and D. J. Lefer Pretreatment With Simvastatin Attenuates Myocardial Dysfunction After Ischemia and Chronic Reperfusion Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 2059 - 2064. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikeda, L. H Young, R. Scalia, C. R Ross, and A. M Lefer PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion Cardiovasc Res, January 1, 2001; 49(1): 69 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Park and B. R. Lucchesi Mechanisms of myocardial reperfusion injury Ann. Thorac. Surg., November 1, 1999; 68(5): 1905 - 1912. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, Y. Sawa, H. Ichikawa, Y. Kaneda, and H. Matsuda Myocardial protection with endogenous overexpression of manganese superoxide dismutase Ann. Thorac. Surg., October 1, 1999; 68(4): 1266 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wang, H. Chen, H. Qin, S. Sankarapandi, M. W. Becher, P. C. Wong, and J. L. Zweier Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury PNAS, April 14, 1998; 95(8): 4556 - 4560. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Simonian, H. Dardik, D. Hallac, R. Mazziotta, I. Ibrahim, and R. Stahl Hemodynamic and Histopathologic Effects of Hydroxyethyl Starch and Superoxide Dismutase Following Splanchnic Arterial Occlusion in a Murine Model Vascular and Endovascular Surgery, September 1, 1997; 31(5): 645 - 656. [Abstract] [PDF] |
||||
![]() |
D. Zahger, J. Yano, A. Chaux, M. C. Fishbein, and W. Ganz Absence of Lethal Reperfusion Injury After 3 Hours of Reperfusion : A Study in a Single-Canine-Heart Model of Ischemia-Reperfusion Circulation, June 15, 1995; 91(12): 2989 - 2994. [Abstract] [Full Text] |
||||
![]() |
R. S. Finley Overview of Biotechnology in Health Care Journal of Pharmacy Practice, January 1, 1991; 4(2): 80 - 86. [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |